Cargando…

Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson’s disease

BACKGROUND: Fear of falling is common in people with Parkinson’s disease (PD) and is associated with an increased risk for future falls, activity limitations and a reduced quality of life. The Falls Efficacy Scale-International (FES-I) assesses fear of falling conceptualized as concerns about fallin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonasson, Stina B, Nilsson, Maria H, Lexell, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452359/
https://www.ncbi.nlm.nih.gov/pubmed/28569162
http://dx.doi.org/10.1186/s12955-017-0689-6
_version_ 1783240398653620224
author Jonasson, Stina B
Nilsson, Maria H
Lexell, Jan
author_facet Jonasson, Stina B
Nilsson, Maria H
Lexell, Jan
author_sort Jonasson, Stina B
collection PubMed
description BACKGROUND: Fear of falling is common in people with Parkinson’s disease (PD) and is associated with an increased risk for future falls, activity limitations and a reduced quality of life. The Falls Efficacy Scale-International (FES-I) assesses fear of falling conceptualized as concerns about falling. The original FES-I has good psychometric properties in people with PD, but whether this applies also for the short version of FES-I remains to be shown. The aim of the present study was to evaluate the psychometric properties of the short FES-I and to compare these with the original FES-I in the same sample of people with PD. The investigated psychometric properties included known groups validity, data completeness, scaling assumptions, targeting and reliability. METHODS: A postal survey, which included the original, full-length FES-I, was distributed to 174 people with PD. Responders received a second survey after two weeks. From these data, short FES-I total scores were calculated by extracting the items that are included in the short version of the scale. RESULTS: Median age and PD duration of the 101 responders (43% women) were 73 and 5 years, respectively. The original as well as the short FES-I scores were able to discriminate (p < 0.001) between groups with and without fear of falling, activity avoidance, falls, near falls, and with various self-rated PD severity, respectively. Both versions of FES-I had a high level of data completeness (0.7 to 0.9% missing item responses). Scaling assumptions were acceptable for the original as well as the short FES-I. While the short FES-I had 19% floor effect, the original version was better targeted. Both versions were reliable and obtained high values for internal consistency (Cronbach’s alpha >0.8) and test-retest reliability (Intraclass Correlation Coefficient > 0.9). CONCLUSIONS: Both the original and short FES-I revealed generally good psychometric properties in people with PD, although the original scale was better targeted. Due to the higher floor effect in the short FES-I, the present findings favors using the original, full-length FES-I in longitudinal follow-ups, intervention studies and clinical practice when addressing concerns about falling.
format Online
Article
Text
id pubmed-5452359
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54523592017-06-01 Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson’s disease Jonasson, Stina B Nilsson, Maria H Lexell, Jan Health Qual Life Outcomes Research BACKGROUND: Fear of falling is common in people with Parkinson’s disease (PD) and is associated with an increased risk for future falls, activity limitations and a reduced quality of life. The Falls Efficacy Scale-International (FES-I) assesses fear of falling conceptualized as concerns about falling. The original FES-I has good psychometric properties in people with PD, but whether this applies also for the short version of FES-I remains to be shown. The aim of the present study was to evaluate the psychometric properties of the short FES-I and to compare these with the original FES-I in the same sample of people with PD. The investigated psychometric properties included known groups validity, data completeness, scaling assumptions, targeting and reliability. METHODS: A postal survey, which included the original, full-length FES-I, was distributed to 174 people with PD. Responders received a second survey after two weeks. From these data, short FES-I total scores were calculated by extracting the items that are included in the short version of the scale. RESULTS: Median age and PD duration of the 101 responders (43% women) were 73 and 5 years, respectively. The original as well as the short FES-I scores were able to discriminate (p < 0.001) between groups with and without fear of falling, activity avoidance, falls, near falls, and with various self-rated PD severity, respectively. Both versions of FES-I had a high level of data completeness (0.7 to 0.9% missing item responses). Scaling assumptions were acceptable for the original as well as the short FES-I. While the short FES-I had 19% floor effect, the original version was better targeted. Both versions were reliable and obtained high values for internal consistency (Cronbach’s alpha >0.8) and test-retest reliability (Intraclass Correlation Coefficient > 0.9). CONCLUSIONS: Both the original and short FES-I revealed generally good psychometric properties in people with PD, although the original scale was better targeted. Due to the higher floor effect in the short FES-I, the present findings favors using the original, full-length FES-I in longitudinal follow-ups, intervention studies and clinical practice when addressing concerns about falling. BioMed Central 2017-05-31 /pmc/articles/PMC5452359/ /pubmed/28569162 http://dx.doi.org/10.1186/s12955-017-0689-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Jonasson, Stina B
Nilsson, Maria H
Lexell, Jan
Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson’s disease
title Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson’s disease
title_full Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson’s disease
title_fullStr Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson’s disease
title_full_unstemmed Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson’s disease
title_short Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson’s disease
title_sort psychometric properties of the original and short versions of the falls efficacy scale-international (fes-i) in people with parkinson’s disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452359/
https://www.ncbi.nlm.nih.gov/pubmed/28569162
http://dx.doi.org/10.1186/s12955-017-0689-6
work_keys_str_mv AT jonassonstinab psychometricpropertiesoftheoriginalandshortversionsofthefallsefficacyscaleinternationalfesiinpeoplewithparkinsonsdisease
AT nilssonmariah psychometricpropertiesoftheoriginalandshortversionsofthefallsefficacyscaleinternationalfesiinpeoplewithparkinsonsdisease
AT lexelljan psychometricpropertiesoftheoriginalandshortversionsofthefallsefficacyscaleinternationalfesiinpeoplewithparkinsonsdisease